Novavax, Inc. (NVAX)
10.60
+0.05
(+0.47%)
USD |
NASDAQ |
Sep 24, 16:00
10.56
-0.04
(-0.38%)
After-Hours: 06:35
Novavax Gross Profit (Annual) : 1.052B for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.052B |
| December 31, 2024 | 484.22M |
| December 31, 2023 | 704.24M |
| December 31, 2022 | 1.079B |
| December 31, 2021 | 1.134B |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 30.27M |
| December 31, 2014 | 15.67M |
| December 31, 2013 | 12.69M |
| December 31, 2012 | 7.384M |
| December 31, 2011 | 7.685M |
| December 31, 2010 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| December 31, 2007 | -1.637M |
| December 31, 2006 | -1.79M |
| December 31, 2005 | 0.078M |
| December 31, 2004 | 4.77M |
| December 31, 2003 | 9.728M |
| December 31, 2002 | 11.45M |
| December 31, 2001 | 15.89M |
| December 31, 2000 | -6.883M |
| December 31, 1999 | -2.173M |
| December 31, 1998 | -2.68M |
| December 31, 1997 | -2.354M |
| December 31, 1996 | -3.66M |
| December 31, 1995 | -3.44M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Moderna, Inc. | 861.00M |
| Merck & Co., Inc. | 46.73B |
| Pfizer Inc. | 41.04B |
| Recursion Pharmaceuticals, Inc. | -46.27M |
| Agenus, Inc. | 103.18M |